Now or never? The case for cell-based immunosuppression in kidney transplantation

Kidney International
James A Hutchinson, Edward K Geissler

Abstract

By exploiting mechanisms of immunological regulation against donor alloantigen, it may be possible to reduce the dependence of kidney transplant recipients upon calcineurin inhibitor-based maintenance immunosuppression. One means to strengthen regulatory responses is treating recipients with preparations of regulatory cells obtained by ex vivo manipulation. This strategy, which is a well-established experimental method, has been developed to the point that early-phase clinical trials in kidney transplantation are now feasible. Cell-based therapies represent a radical departure from conventional treatment, so what grounds are there for this new approach? This article offers a three-part justification for trialing cell-based therapies in kidney transplantation: first, a clinical need for alternatives to standard immunosuppression is identified, based on the inadequacies of calcineurin inhibitor-based regimens in preventing late allograft loss; second, a mechanistic explanation of how cell-based therapies might address this clinical need is given; and third, the possible benefit to patients is weighed against the potential risks of cell-based immunosuppressive therapy. It is concluded that the safety of cell-based immunosuppressiv...Continue Reading

References

Feb 12, 1993·Science·S QinH Waldmann
Jun 27, 2003·Transplant International : Official Journal of the European Society for Organ Transplantation·Elly M van DuijnhovenJohannes P van Hooff
Mar 5, 2005·Blood·Manuela BattagliaMaria-Grazia Roncarolo
Jan 25, 2008·The New England Journal of Medicine·Tatsuo KawaiDavid H Sachs
Jun 25, 2008·Transplant International : Official Journal of the European Society for Organ Transplantation·James A HutchinsonFred Fändrich
Jun 25, 2008·Transplant International : Official Journal of the European Society for Organ Transplantation·James A HutchinsonFred Fändrich
Jun 25, 2008·Transplant International : Official Journal of the European Society for Organ Transplantation·James A HutchinsonFred Fändrich
Mar 14, 2009·European Journal of Immunology·Petra HoffmannMatthias Edinger
May 9, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Y LebranchuB Hurault de Ligny
May 26, 2009·Immunity·Maria A Curotto de Lafaille, Juan J Lafaille
Jun 23, 2009·Transplantation·Martin GallagherJosette Eris
Jun 30, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Piotr TrzonkowskiAndrzej Hellmann
Jul 1, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·H EkbergP Halloran
Jul 2, 2009·Proceedings of the National Academy of Sciences of the United States of America·Stephen P CobboldHerman Waldmann
Apr 9, 2010·Medical Microbiology and Immunology·Eliana RibechiniManfred B Lutz
May 27, 2010·The Journal of Clinical Investigation·Pervinder SagooRobert I Lechler
May 27, 2010·The Journal of Clinical Investigation·Kenneth A NewellUNKNOWN Immune Tolerance Network ST507 Study Group
Jun 17, 2010·Annals of the Rheumatic Diseases·Rachel A HarryCatharien M U Hilkens
Aug 10, 2010·Transplantation Proceedings·C Ponticelli, M P Scolari
Dec 1, 2010·Kidney International. Supplement·Niloufar SafiniaRobert I Lechler
Jun 8, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·G AndreolaM Sykes
Aug 2, 2011·Current Opinion in Immunology·Matthias Edinger, Petra Hoffmann
Aug 2, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·James A HutchinsonFred Fändrich
Sep 3, 2011·Current Opinion in Nephrology and Hypertension·Michael Jin Casey, Herwig-Ulf Meier-Kriesche
Sep 29, 2011·Journal of the American Society of Nephrology : JASN·Adnan SharifRichard Borrows
Dec 6, 2011·Annual Review of Immunology·Ralph M Steinman
Dec 7, 2011·Current Opinion in Organ Transplantation·Ulrike SchliesserBirgit Sawitzki
Dec 22, 2011·Current Opinion in Organ Transplantation·James A HutchinsonEdward K Geissler
May 25, 2012·Kidney International·Flavio Vincenti
May 26, 2012·Nature Reviews. Immunology·Kathryn J WoodJoanna Hester
Jun 19, 2012·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A SiepertP Reinke
Jul 14, 2012·Current Opinion in Organ Transplantation·Christiane BroichhausenJames A Hutchinson
Jul 14, 2012·Current Opinion in Organ Transplantation·Katherine G MacDonaldMegan K Levings
Aug 2, 2012·Chimerism·William J Burlingham, Gilles Benichou

❮ Previous
Next ❯

Citations

Nov 19, 2015·Kidney International·Mohamed B EzzelarabAngus W Thomson
Nov 19, 2015·Kidney International·James A Hutchinson, Edward K Geissler
Jan 29, 2016·Mediators of Inflammation·Anja Ten BrinkeEva M Martinez-Caceres
Dec 5, 2015·Frontiers in Immunology·Silvia GregoriMaria-Grazia Roncarolo
Jun 17, 2015·Langenbeck's Archives of Surgery·Christian MorathChristian Kleist
May 3, 2016·Journal of Autoimmunity·Stephen E Gitelman, Jeffrey A Bluestone
Jun 7, 2016·Kidney International·Min HuStephen I Alexander
Dec 25, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M B EzzelarabA W Thomson
Jul 28, 2016·Lancet·James A Hutchinson, Carsten A Böger
May 26, 2017·Transplant International : Official Journal of the European Society for Organ Transplantation·James A HutchinsonEdward K Geissler
Jul 21, 2017·American Journal of Physiology. Renal Physiology·Jennifer C Sullivan, Ellen E Gillis
Jun 9, 2017·Transplantation·Paloma RiquelmeJames A Hutchinson
Aug 7, 2018·Current Opinion in Organ Transplantation·Angus W Thomson
Jul 31, 2018·Current Opinion in Organ Transplantation·Paloma Riquelme, James A Hutchinson
Jun 6, 2018·Journal of the American Society of Nephrology : JASN·Paul DiefenhardtOliver M Steinmetz
Dec 1, 2017·Transplantation·Joseph R ScaleaJonathan S Bromberg
Feb 18, 2016·Transplantation·Geoff Y ZhangStephen I Alexander
Feb 24, 2016·Transplantation·Damien P Brown, Jeremy R Chapman
Nov 20, 2016·Xenotransplantation·Natacha MadelonJörg D Seebach
Feb 24, 2017·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Christian MorathChristian Kleist
Jul 22, 2018·Nature Communications·Paloma RiquelmeJames A Hutchinson
May 23, 2017·Current Transplantation Reports·Mohamed B Ezzelarab, Angus W Thomson
Jan 9, 2021·International Immunopharmacology·Feilong ZhangWei Wang
Mar 13, 2021·Frontiers in Immunology·Marta FortunatoSilvia Gregori
Aug 8, 2021·International Journal of Molecular Sciences·Maaike Suuring, Aurélie Moreau
Mar 24, 2021·Transplantation·Jennifer LiNatasha M Rogers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.